Hospital
Kettering Medical Center
Kettering Medical Center was paid $20.00M by Medicaid between Jan 2018 and Dec 2024, across 256 billing codes. Its largest line is 99283, emergency room visit (moderate) — 18% of everything it billed.
33Billing provider infoKETTERING MEDICAL CENTER
MIAMISBURG, OH 45342
MIAMISBURG, OH 45342
33aNPI1316966518assigned 07/19/2006
33bProvider typePsychiatric Hospital Unit
28Total paid$20.00M
24GClaims465,851
24DCodes billed256
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Psychiatric Hospital Unit providers in Ohio
Rank by total paid#5 of 6
Median peer was paid$22.82M
This provider vs. median0.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official KO, TIMOTHY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 35,247 | $1.54M | |
| 2019 | 25,517 | $1.27M | |
| 2020 | 15,993 | $1.09M | |
| 2021 | 23,169 | $1.36M | |
| 2022 | 37,309 | $1.85M | |
| 2023 | 186,020 | $7.77M | |
| 2024incomplete | 142,596 | $5.12M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 18% | 32,079 | 29,545 | $3.67M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 20,912 | 18,917 | $2.73M |
| 96361 | Intravenous infusion, hydration; each additional hour | 13% | 9,530 | 6,521 | $2.69M |
| 29581 | 6.5% | 13,116 | 3,442 | $1.30M | |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.2% | 6,798 | 5,688 | $846K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 3.7% | 9,851 | 7,816 | $732K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.6% | 3,084 | 2,597 | $720K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.2% | 2,646 | 2,240 | $632K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2.7% | 2,130 | 1,787 | $549K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 2.1% | 811 | 738 | $413K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.5% | 2,519 | 2,348 | $308K |
| 62323 | 1.4% | 725 | 636 | $287K |
244 more codes
| G0378 | Hospital observation service, per hour | 1.4% | 4,148 | $279K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.4% | 1,349 | $274K |
| G0260 | Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography | 1.3% | 1,216 | $256K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.2% | 2,339 | $249K |
| H2020 | Therapeutic behavioral services, per diem | 1.0% | 1,623 | $207K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 717 | $195K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,314 | $189K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 2,709 | $184K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 29,476 | $159K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,454 | $156K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,246 | $152K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 1,210 | $146K |
| 64493 | <1% | 199 | $141K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 220 | $136K |
| 64483 | <1% | 270 | $121K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 6,754 | $114K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 2,920 | $106K |
| 76642 | <1% | 824 | $104K | |
| 62321 | <1% | 229 | $103K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 670 | $101K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 456 | $87K |
| G0238 | Therapeutic procedures to improve respiratory function, other than described by g0237, one on one, face to face, per 15 minutes (includes monitoring) | <1% | 525 | $76K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,592 | $73K |
| 71250 | <1% | 646 | $58K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 736 | $55K |
| 76830 | Ultrasound, transvaginal | <1% | 660 | $54K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,183 | $52K |
| 80053 | Comprehensive metabolic panel | <1% | 4,378 | $50K |
| 70496 | <1% | 180 | $49K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 434 | $43K |
| 93971 | <1% | 645 | $37K | |
| 72131 | <1% | 687 | $34K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 36,560 | $31K |
| 97162 | <1% | 834 | $31K | |
| 95811 | <1% | 41 | $31K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 161 | $30K |
| 20610 | <1% | 154 | $29K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,266 | $29K |
| 71271 | <1% | 175 | $27K | |
| 97161 | <1% | 438 | $22K | |
| 77065 | Tomosynthesis, mammo | <1% | 611 | $22K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,067 | $21K |
| 82805 | <1% | 969 | $20K | |
| 64635 | <1% | 39 | $20K | |
| 12001 | <1% | 130 | $20K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,164 | $19K |
| 93356 | <1% | 86 | $19K | |
| 93970 | <1% | 172 | $18K | |
| 73030 | <1% | 920 | $18K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 1,268 | $18K |
| 80061 | Lipid panel | <1% | 1,836 | $17K |
| 71045 | Radiologic examination, chest; single view | <1% | 7,879 | $17K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,783 | $17K |
| 72100 | <1% | 530 | $17K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 12,525 | $17K |
| 97166 | <1% | 527 | $17K | |
| 74018 | <1% | 467 | $16K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 11,215 | $16K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 821 | $16K |
| 77066 | Tomosynthesis, mammo | <1% | 432 | $16K |
| 82607 | <1% | 1,259 | $16K | |
| 73630 | <1% | 1,098 | $15K | |
| 84484 | <1% | 10,175 | $14K | |
| 80076 | <1% | 8,809 | $14K | |
| 73562 | <1% | 567 | $14K | |
| 86850 | <1% | 719 | $13K | |
| J3490 | Unclassified drugs | <1% | 3,820 | $12K |
| 82728 | <1% | 1,115 | $11K | |
| 96367 | <1% | 493 | $11K | |
| 97116 | <1% | 477 | $11K | |
| 84439 | <1% | 886 | $11K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,782 | $11K |
| 73130 | <1% | 787 | $10K | |
| 86900 | <1% | 923 | $10K | |
| 80069 | <1% | 2,056 | $10K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 11,923 | $10K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 84 | $9K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 271 | $9K |
| 72110 | <1% | 152 | $9K | |
| 73610 | <1% | 757 | $9K | |
| 73560 | <1% | 623 | $9K | |
| 70486 | <1% | 303 | $9K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 47 | $8K |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 331 | $8K |
| 64494 | <1% | 361 | $8K | |
| 90715 | <1% | 545 | $8K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 723 | $8K |
| 93017 | <1% | 97 | $7K | |
| 43235 | <1% | 13 | $7K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 7,549 | $7K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 7,818 | $7K |
| 73502 | <1% | 438 | $7K | |
| 83540 | <1% | 1,150 | $7K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 545 | $6K |
| 76536 | <1% | 54 | $6K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 25 | $6K |
| 73110 | <1% | 506 | $5K | |
| 27096 | <1% | 27 | $5K | |
| 83550 | <1% | 1,110 | $5K | |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | <1% | 369 | $5K |
| 88307 | <1% | 33 | $5K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 21 | $5K |
| 72128 | <1% | 241 | $5K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 7,003 | $4K |
| 83735 | <1% | 3,354 | $4K | |
| 85027 | <1% | 1,419 | $4K | |
| 81001 | <1% | 12,198 | $4K | |
| 72040 | <1% | 110 | $4K | |
| 10060 | <1% | 26 | $4K | |
| J1610 | Injection, glucagon hydrochloride, per 1 mg | <1% | 19 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,053 | $3K |
| 96376 | <1% | 1,989 | $3K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,852 | $3K |
| 82746 | <1% | 1,058 | $3K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,015 | $3K |
| 85610 | <1% | 2,209 | $3K | |
| 87529 | <1% | 1,656 | $2K | |
| 73590 | <1% | 243 | $2K | |
| 81025 | <1% | 6,715 | $2K | |
| 84425 | <1% | 469 | $2K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 15 | $2K |
| 84590 | <1% | 443 | $2K | |
| 83880 | <1% | 1,053 | $2K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,015 | $2K |
| 88341 | <1% | 15 | $2K | |
| 97165 | <1% | 34 | $2K | |
| 84702 | <1% | 572 | $2K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 974 | $1K |
| 73080 | <1% | 153 | $1K | |
| 94060 | <1% | 12 | $1K | |
| 83690 | <1% | 7,060 | $1K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 31 | $1K |
| 77002 | <1% | 284 | $1K | |
| 71101 | <1% | 107 | $1K | |
| 87077 | <1% | 1,225 | $1K | |
| 86803 | <1% | 32 | $1K | |
| 85007 | <1% | 694 | $1K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 1,957 | $1K |
| 81003 | <1% | 1,980 | $1K | |
| 94726 | <1% | 12 | $979.16 | |
| 85651 | <1% | 593 | $976.66 | |
| 73090 | <1% | 86 | $911.25 | |
| 84100 | <1% | 540 | $882.24 | |
| 85378 | <1% | 1,570 | $870.88 | |
| 86140 | <1% | 114 | $866.55 | |
| J7999 | Compounded drug, not otherwise classified | <1% | 361 | $846.95 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,436 | $842.87 |
| 70498 | <1% | 175 | $834.86 | |
| 94729 | <1% | 13 | $811.20 | |
| 83605 | <1% | 1,999 | $803.21 | |
| 72050 | <1% | 12 | $792.45 | |
| 82550 | <1% | 589 | $740.93 | |
| 29125 | <1% | 404 | $740.33 | |
| 87634 | <1% | 334 | $732.86 | |
| 87210 | <1% | 623 | $673.27 | |
| 84436 | <1% | 379 | $668.11 | |
| 92610 | <1% | 33 | $617.45 | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | <1% | 232 | $612.90 |
| 87186 | <1% | 914 | $590.31 | |
| 82248 | <1% | 214 | $569.63 | |
| 84145 | <1% | 1,068 | $536.16 | |
| 86901 | <1% | 923 | $529.98 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,281 | $516.27 |
| J2800 | Injection, methocarbamol, up to 10 ml | <1% | 177 | $412.67 |
| 72072 | <1% | 12 | $402.38 | |
| 87040 | <1% | 1,712 | $393.11 | |
| 73140 | <1% | 62 | $381.74 | |
| 82043 | <1% | 69 | $370.66 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 9,342 | $356.81 |
| J0744 | Injection, ciprofloxacin for intravenous infusion, 200 mg | <1% | 358 | $323.97 |
| 76870 | <1% | 15 | $320.81 | |
| 84550 | <1% | 54 | $309.82 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 7,393 | $272.48 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 3,679 | $268.07 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 3,992 | $265.59 |
| 84132 | <1% | 495 | $253.91 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,514 | $222.09 |
| 96368 | <1% | 12 | $207.89 | |
| 86141 | <1% | 81 | $201.14 | |
| J2310 | Injection, naloxone hydrochloride, per 1 mg | <1% | 21 | $190.33 |
| 73552 | <1% | 17 | $166.55 | |
| 84153 | <1% | 12 | $158.28 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 939 | $129.53 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 260 | $111.26 |
| 72170 | <1% | 31 | $111.02 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 356 | $107.97 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 146 | $105.18 |
| 82330 | <1% | 69 | $103.95 | |
| 82570 | <1% | 14 | $103.37 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 380 | $101.51 |
| J2704 | Injection, propofol, 10 mg | <1% | 1,411 | $91.97 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,512 | $91.75 |
| 84703 | <1% | 135 | $87.29 | |
| 87070 | <1% | 226 | $83.85 | |
| 80320 | <1% | 18 | $80.28 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 1,144 | $65.44 |
| 85730 | <1% | 484 | $62.08 | |
| 85014 | <1% | 19 | $58.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,436 | $57.93 |
| 82010 | <1% | 174 | $50.33 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,241 | $44.56 |
| 87205 | <1% | 34 | $44.49 | |
| 85018 | <1% | 19 | $42.43 | |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 518 | $41.49 |
| 88342 | <1% | 892 | $39.36 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 371 | $36.94 |
| 01999 | <1% | 289 | $36.35 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 872 | $31.90 |
| 82140 | <1% | 59 | $31.22 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 48 | $23.15 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 384 | $21.95 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 312 | $12.00 |
| J3360 | Injection, diazepam, up to 5 mg | <1% | 33 | $11.56 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 181 | $9.68 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 886 | $9.45 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 1,483 | $9.10 |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 111 | $5.01 |
| J2470 | Injection, pantoprazole sodium, 40 mg | <1% | 118 | $3.85 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 228 | $3.00 |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 202 | $2.53 |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 36 | $2.34 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,261 | $1.79 |
| Q0177 | Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 140 | $0.37 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | <1% | 369 | $0.12 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 0% | 87 | $0.00 |
| C1751 | Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) | 0% | 58 | $0.00 |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | 0% | 496 | $0.00 |
| 00731 | 0% | 432 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 36 | $0.00 |
| J1020 | Injection, methylprednisolone acetate, 20 mg | 0% | 34 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 171 | $0.00 |
| 64636 | 0% | 37 | $0.00 | |
| 00797 | 0% | 27 | $0.00 | |
| C1776 | Joint device (implantable) | 0% | 13 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 21 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 410 | $0.00 |
| 88304 | 0% | 220 | $0.00 | |
| 00813 | 0% | 28 | $0.00 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 79 | $0.00 |
| A4648 | Tissue marker, implantable, any type, each | 0% | 248 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 167 | $0.00 |
| 94760 | 0% | 83 | $0.00 | |
| 88311 | 0% | 16 | $0.00 | |
| C1769 | Guide wire | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKO, TIMOTHY (KETTERING HEALTH CFO)
| Provider | Location | Paid |
|---|---|---|
| Dayton Osteopathic Hospital | Dayton, OH | $111.27M |
| Alliance Physicians INC | Kettering, OH | $38.76M |
| Kettering Medical Center | Kettering, OH | $37.96M |
| Beavercreek Medical Center | Beavercreek, OH | $30.49M |
| The Fort Hamilton Hospital | Hamilton, OH | $27.06M |
| Greene Memorial Hospital INC | Xenia, OH | $11.31M |
| Kettering Medical Center | Troy, OH | $10.83M |
| Kettering Independent Medical Group INC | Miamisburg, OH | $8.39M |
| Kettering Affiliated Health Services | Miamisburg, OH | $2.12M |
| Greene Memorial Hospital, INC. | Jamestown, OH | $1.53M |
| Alliance Physicians INC | Moraine, OH | $1.42M |
| Alliance Physicians INC | Huber Heights, OH | $1.06M |
| Greene Memorial Hospital INC | Yellow Springs, OH | $843K |
| Alliance Physicians INC | Miamisburg, OH | $744K |
| Greene Memorial Hospital INC | Cedarville, OH | $703K |
| Alliance Physicians INC | Xenia, OH | $645K |
| Alliance Physicians INC | Springboro, OH | $616K |
| Alliance Physicians INC | Kettering, OH | $599K |
| Sycamore Primary Care Group | Miamisburg, OH | $564K |
| Alliance Physicians INC | Beavercreek, OH | $486K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.